In compounding, speed is essential, but choosing an analytical testing lab on price and turnaround alone introduces real risk to product quality and patient safety. This business case explains why 503A pharmacies face testing needs unlike the broader pharmaceutical industry, outlines the FDA enforcement actions already reaching 503As, and identifies five red flags that signal a contract lab may not be upholding the necessary quality standards. Download it to learn what to demand from your testing partner.
Download our white paper to learn more about High-Quality Analytical Testing
